THE EFFICACY AND SAFETY OF LEBRIKIZUMAB PLUS TOPICAL CORTICOSTEDOIDS IN MODERATETO SEVERE ATOPIC DERMATITIS. Cuestiones de Fisioterapia, [S. l.], v. 53, n. 03, p. 6987–6993, 2024. DOI: 10.48047/vwmbcr61. Disponível em: https://cuestionesdefisioterapia.com/index.php/es/article/view/3988.. Acesso em: 18 mar. 2026.